2-[4-tert-butyl-6-[4-tert-butyl-6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;2-[[5-[[3,4-diethyl-5-[(3,4,5-trimethylpyrrol-2-ylidene)methyl]pyrrol-1-id-2-yl]methylidene]-3,4-diethylpyrrol-1-id-2-ylidene]methyl]pyridine;2-[6-[2-[6-(2-hydroxyphenyl)-2-pyridinyl]propan-2-yl]-2-pyridinyl]phenol;3-methyl-2-[6-[[6-(3-methylindol-1-id-2-yl)-2-pyridinyl]methyl]-2-pyridinyl]indol-1-ide;platinum;tetrakis(platinum(2+));2-pyrrol-1-id-2-yl-6-[(6-pyrrol-1-id-2-yl-2-pyridinyl)methyl]pyridine;2-(3,4,5-trimethylpyrrol-1-id-2-yl)-6-[[6-(3,4,5-trimethylpyrrol-1-id-2-yl)-2-pyridinyl]methyl]pyridine
C159H152N20O4Pt6 — CID 158345891
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-tert-butyl-6-[4-tert-butyl-6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;2-[[5-[[3,4-diethyl-5-[(3,4,5-trimethylpyrrol-2-ylidene)methyl]pyrrol-1-id-2-yl]methylidene]-3,4-diethylpyrrol-1-id-2-ylidene]methyl]pyridine;2-[6-[2-[6-(2-hydroxyphenyl)-2-pyridinyl]propan-2-yl]-2-pyridinyl]phenol;3-methyl-2-[6-[[6-(3-methylindol-1-id-2-yl)-2-pyridinyl]methyl]-2-pyridinyl]indol-1-ide;platinum;tetrakis(platinum(2+));2-pyrrol-1-id-2-yl-6-[(6-pyrrol-1-id-2-yl-2-pyridinyl)methyl]pyridine;2-(3,4,5-trimethylpyrrol-1-id-2-yl)-6-[[6-(3,4,5-trimethylpyrrol-1-id-2-yl)-2-pyridinyl]methyl]pyridine
2-[4-tert-butyl-6-[4-tert-butyl-6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;2-[[5-[[3,4-diethyl-5-[(3,4,5-trimethylpyrrol-2-ylidene)methyl]pyrrol-1-id-2-yl]methylidene]-3,4-diethylpyrrol-1-id-2-ylidene]methyl]pyridine;2-[6-[2-[6-(2-hydroxyphenyl)-2-pyridinyl]propan-2-yl]-2-pyridinyl]phenol;3-methyl-2-[6-[[6-(3-methylindol-1-id-2-yl)-2-pyridinyl]methyl]-2-pyridinyl]indol-1-ide;platinum;tetrakis(platinum(2+));2-pyrrol-1-id-2-yl-6-[(6-pyrrol-1-id-2-yl-2-pyridinyl)methyl]pyridine;2-(3,4,5-trimethylpyrrol-1-id-2-yl)-6-[[6-(3,4,5-trimethylpyrrol-1-id-2-yl)-2-pyridinyl]methyl]pyridine (PubChem CID 158345891) has the molecular formula C159H152N20O4Pt6 and a molecular weight of 3577.57 g/mol. Its IUPAC name is 2-[4-tert-butyl-6-[4-tert-butyl-6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;2-[[5-[[3,4-diethyl-5-[(3,4,5-trimethylpyrrol-2-ylidene)methyl]pyrrol-1-id-2-yl]methylidene]-3,4-diethylpyrrol-1-id-2-ylidene]methyl]pyridine;2-[6-[2-[6-(2-hydroxyphenyl)-2-pyridinyl]propan-2-yl]-2-pyridinyl]phenol;3-methyl-2-[6-[[6-(3-methylindol-1-id-2-yl)-2-pyridinyl]methyl]-2-pyridinyl]indol-1-ide;platinum;tetrakis(platinum(2+));2-pyrrol-1-id-2-yl-6-[(6-pyrrol-1-id-2-yl-2-pyridinyl)methyl]pyridine;2-(3,4,5-trimethylpyrrol-1-id-2-yl)-6-[[6-(3,4,5-trimethylpyrrol-1-id-2-yl)-2-pyridinyl]methyl]pyridine.
Molecular Properties
| Compound Name | 2-[4-tert-butyl-6-[4-tert-butyl-6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;2-[[5-[[3,4-diethyl-5-[(3,4,5-trimethylpyrrol-2-ylidene)methyl]pyrrol-1-id-2-yl]methylidene]-3,4-diethylpyrrol-1-id-2-ylidene]methyl]pyridine;2-[6-[2-[6-(2-hydroxyphenyl)-2-pyridinyl]propan-2-yl]-2-pyridinyl]phenol;3-methyl-2-[6-[[6-(3-methylindol-1-id-2-yl)-2-pyridinyl]methyl]-2-pyridinyl]indol-1-ide;platinum;tetrakis(platinum(2+));2-pyrrol-1-id-2-yl-6-[(6-pyrrol-1-id-2-yl-2-pyridinyl)methyl]pyridine;2-(3,4,5-trimethylpyrrol-1-id-2-yl)-6-[[6-(3,4,5-trimethylpyrrol-1-id-2-yl)-2-pyridinyl]methyl]pyridine |
|---|---|
| PubChem CID | 158345891 |
| Molecular Formula | C159H152N20O4Pt6 |
| Molecular Weight | 3577.57 g/mol |
| Exact Mass | 3575.02 |
| IUPAC Name | 2-[4-tert-butyl-6-[4-tert-butyl-6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;2-[[5-[[3,4-diethyl-5-[(3,4,5-trimethylpyrrol-2-ylidene)methyl]pyrrol-1-id-2-yl]methylidene]-3,4-diethylpyrrol-1-id-2-ylidene]methyl]pyridine;2-[6-[2-[6-(2-hydroxyphenyl)-2-pyridinyl]propan-2-yl]-2-pyridinyl]phenol;3-methyl-2-[6-[[6-(3-methylindol-1-id-2-yl)-2-pyridinyl]methyl]-2-pyridinyl]indol-1-ide;platinum;tetrakis(platinum(2+));2-pyrrol-1-id-2-yl-6-[(6-pyrrol-1-id-2-yl-2-pyridinyl)methyl]pyridine;2-(3,4,5-trimethylpyrrol-1-id-2-yl)-6-[[6-(3,4,5-trimethylpyrrol-1-id-2-yl)-2-pyridinyl]methyl]pyridine |
| SMILES | CC(C)(C)c1cc(-c2cc(C(C)(C)C)cc(-c3ccccc3O)n2)nc(-c2ccccc2O)c1.CC(C)(c1cccc(-c2ccccc2O)n1)c1cccc(-c2ccccc2O)n1.CCc1c(C=C2N=C(C)C(C)=C2C)[n-]c(C=c2[n-]c(=Cc3ccccn3)c(CC)c2CC)c1CC.Cc1[n-]c(-c2cccc(Cc3cccc(-c4[n-]c(C)c(C)c4C)n3)n2)c(C)c1C.Cc1c(-c2cccc(Cc3cccc(-c4[n-]c5ccccc5c4C)n3)n2)[n-]c2ccccc12.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].[Pt].c1cc(Cc2cccc(-c3ccc[n-]3)n2)nc(-c2ccc[n-]2)c1 |
| InChI | InChI=1S/C31H36N4.C30H32N2O2.C29H22N4.C25H26N4.C25H22N2O2.C19H14N4.6Pt/c1-8-23-24(9-2)30(34-28(23)16-22-14-12-13-15-32-22)18-31-26(11-4)25(10-3)29(35-31)17-27-20(6)19(5)21(7)33-27;1-29(2,3)19-15-23(21-11-7-9-13-27(21)33)31-25(17-19)26-18-20(30(4,5)6)16-24(32-26)22-12-8-10-14-28(22)34;1-18-22-11-3-5-13-24(22)32-28(18)26-15-7-9-20(30-26)17-21-10-8-16-27(31-21)29-19(2)23-12-4-6-14-25(23)33-29;1-14-16(3)24(26-18(14)5)22-11-7-9-20(28-22)13-21-10-8-12-23(29-21)25-17(4)15(2)19(6)27-25;1-25(2,23-15-7-11-19(26-23)17-9-3-5-13-21(17)28)24-16-8-12-20(27-24)18-10-4-6-14-22(18)29;1-5-14(22-18(7-1)16-9-3-11-20-16)13-15-6-2-8-19(23-15)17-10-4-12-21-17;;;;;;/h12-18H,8-11H2,1-7H3;7-18,33-34H,1-6H3;3-16H,17H2,1-2H3;7-12H,13H2,1-6H3;3-16,28-29H,1-2H3;1-12H,13H2;;;;;;/q-2;;2*-2;;-2;;;4*+2 |
| InChIKey | BZMVUDWLLKMWAF-UHFFFAOYSA-N |
| XLogP | 32.79 |
| TPSA | 347.87 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 189 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3577.57 |
| LogP ≤ 5 | 32.79 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158345891 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.